Less Ads, More Data, More Tools Register for FREE

Pin to quick picksManolete Partn. Regulatory News (MANO)

Share Price Information for Manolete Partn. (MANO)

Share Price is delayed by 15 minutes
Get Live Data
39.00    1.00 (2.63%)
Bid:
38.00
Ask:
40.00
Spread: 2.00 (5.263%)
Market Cap: £17.09m
MANO Live PriceLast checked at - London Stock Exchange

Intraday Manolete Partn. Share Chart

Q3 Trading Update

26 Jan 2021 14:47

RNS Number : 9573M
Manolete Partners PLC
26 January 2021
 

26 January 2021

THE INFORMATION COMMUNICATED IN THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 596/2014 ("MAR").

Manolete Partners Plc

("Manolete" or the "Company")

Q3 Trading Update

 

Manolete Partners Plc (AIM: MANO), the leading listed insolvency litigation financing firm in the UK, announces record case completions and record completed case cash inflows but a continued low level of new case investments caused by the ongoing extraordinary UK Government economic support measures. All numbers in this document are unaudited and from internal Company sources.

As highlighted in the Company's interim results for the six months ended 30 September 2020 (announced 10 November 2020), new case enquiries had begun to slow sharply due to the extraordinary UK Government economic support measures that have directly led to a large decrease in the number of UK company insolvencies since the start of the Covid-19 pandemic. This has continued throughout Q3 and into the first few weeks of Q4. The Government measures are planned to continue through to April 2021 at least and so we expect the negative impact on the Company's level of new cases (which continue to be subject to our stringent levels of selection criteria) to persist for the remainder of the current financial year ending 31 March 2021.

In the third quarter of the Company's current financial year ending 31 March 2021, Manolete completed a further 43 insolvency litigation claims bringing the total for the nine months to 31 December 2020 to 95 completed cases. At the time of writing this has now risen to 108 completed cases. This is 100% higher than the 54 cases completions for the whole 12 months of the previous year ended 31 March 2020.

The 95 completed cases for the nine months to 31 December 2020 generated a gross total settlement value of [1]£23.9m, comfortably exceeding board expectations.

Gross cash collected from completed cases in the first nine months to 31 December 2020 increased by 60% to a record £9.3m (nine months ended 31 December 2019: £5.8m). After payments to Insolvent Estates and legal fees, the Company's retained share of this cash increased by 60% to £4.8m (nine months ended 31 December 2019: £3.0m). Cash overheads for the nine-month period were £3.2m (prior year nine-month period: £3.0m), resulting in a cash inflow after payment of operational overheads of £1.5m, compared to an outflow of £32k for the comparable prior year nine-month period. Gross cash generation in Q3 of £5.1m was particularly strong with cash generated from completed cases covering not only all completed case costs and all overheads but also all costs of around 250 ongoing live cases which are expected to generate very significant cash in the Company's normal timeframes.

As a consequence of the above factors, the Board expects realised profits to be above, but unrealised profits to be significantly below, market expectations and therefore for the Company to be overall marginally EBIT profitable in H2.

Longer term, the Board believes that as the UK Government economic support measures are phased out, the longer-term impact of COVID-19 on the UK economy will lead to an increased rate of corporate insolvencies, and will underpin the Company's strong growth prospects for the foreseeable future. The Board will continue to closely monitor the evolving situation and the impact on anticipated levels of litigation finance enquiries in and beyond the near term, and the naturally needed conservatism to be applied to fair values of ongoing cases.

Steven Cooklin, CEO of Manolete, commented: "As we highlighted in our recent interim results, the emergency UK Government actions in response to the pandemic have led to a dramatic decrease in the number of UK insolvencies. This has led to a distorted reality for the economy - many commentators, including last week the Federation for Small Businesses, have highlighted the very high levels of UK companies in significant financial distress. As a consequence, we have a temporary distortion in our new cases and therefore bottom-line profits, though an excellent performance in terms of case completions and strong cash generation. Longer term, the impact of Covid-19 and its consequences on the global economy, is likely to underpin Manolete's strong growth prospects for the foreseeable future".

 

For further information, please contact:

 

Manolete Partners Plc via Instinctif Partners

Steven Cooklin (Chief Executive Officer)

 

Peel Hunt (NOMAD and Sole Broker) +44 (0)20 7418 8900

James Britton

Rishi Shah

Duncan Littlejohns

 

Instinctif Partners (Financial PR)

Tim Linacre +44 (0)7949 939237

 


[1] Includes one case with a discounted revenue of £9.3m as disclosed in the Interim results.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZQLFLFFLZBBQ
Date   Source Headline
1st Jun 20267:00 amRNSBlock Listing Six Monthly Return
20th May 202612:00 pmRNSDirectorate Change
28th Apr 20263:19 pmRNSHolding(s) in Company
24th Apr 20267:00 amRNSFull Year Trading Update
31st Mar 20267:00 amRNSDirectorate Changes
22nd Dec 20257:00 amRNSGrant of Share Options
22nd Dec 20257:00 amRNSGrant of Share Options
17th Dec 20253:13 pmRNSHolding(s) in Company
1st Dec 20257:00 amRNSBlock Listing Six Monthly Return
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20254:10 pmRNSHolding(s) in Company
19th Nov 20257:00 amRNSHalf-year results
4th Nov 20257:00 amRNSNotice of Interim Results
16th Sep 20252:41 pmRNSResult of AGM
16th Sep 20257:00 amRNSAGM Update
22nd Aug 20257:00 amRNSDirectorate Change
20th Aug 202512:11 pmRNSPosting of Annual Report and Notice of AGM
11th Aug 20257:00 amRNSBoard Changes
5th Aug 202510:18 amRNSHolding(s) in Company
5th Aug 202510:17 amRNSHolding(s) in Company
1st Aug 20257:00 amRNSTotal Voting Rights
28th Jul 20258:30 amRNSHolding(s) in Company
21st Jul 20257:00 amRNSTruck Cartel Case Settlement
14th Jul 20257:00 amRNS-RMelloMonday Investor Webinar
9th Jul 20251:45 pmRNSHolding(s) in Company
26th Jun 20257:00 amRNSFull Year Results
25th Jun 20257:00 amRNS-RManolete ranked in Band 1 by Chambers
19th Jun 20252:45 pmRNSHolding(s) in Company
19th Jun 20251:54 pmRNSNotice of Results
30th May 20257:00 amRNSBlock Listing Six Monthly Return
29th Apr 20257:00 amRNSTrading Update
7th Apr 202512:41 pmRNSDirectorate Change
28th Mar 20257:00 amRNSNew Revolving Credit Facility with HSBC Bank
4th Feb 20257:00 amRNSUpdate on Cartel Claims
29th Nov 20247:00 amRNSBlock Listing Six Monthly Return
19th Nov 20247:00 amRNSHalf-year Report
24th Oct 20241:49 pmRNSNotice of Results
17th Oct 202412:35 pmRNSDirector/PDMR Shareholding
30th Sep 202411:49 amRNSResult of AGM
20th Sep 20247:00 amRNSGrant of Share Options
6th Sep 20241:41 pmRNSPosting of Annual Report and Notice of AGM
3rd Sep 20247:00 amRNSAudited results for the year ended 31 March 2024
29th Aug 20247:00 amRNSRetail Investor Presentation
25th Jul 20245:09 pmRNSPCA Shareholding
27th Jun 20247:00 amRNSNotice of Results
31st May 20247:00 amRNSBlock Listing Six Monthly Return
8th May 20247:00 amRNSAppointment of New External Audit Firm
2nd May 20247:00 amRNSChange of Auditor
18th Apr 20247:00 amRNSTrading and Business Update
26th Feb 20247:00 amRNSAppointment of Nominated Adviser and Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.